시장보고서

상품코드

1632629

반려동물 수술 후 통증 관리 치료제 시장 : 시장 규모, 점유율, 동향 분석(동물별, 제품별, 투여 경로별, 최종 용도별), 부문별 예측(2025-2030년)

Companion Animal Postoperative Pain Management Therapeutics Market Size, Share & Trends Analysis Report By Animal, By Product (NSAIDs, Anesthetics), By Route of Administration, By End-use, And Segment Forecasts, 2025 - 2030

발행일: 2024년 12월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

반려동물 수술 후 통증 관리 치료제 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 반려동물 수술 후 통증 관리 치료제 시장 규모는 2030년까지 3억 2,947만 달러에 이르며 2025년에서 2030년까지 연평균 복합 성장률(CAGR) 9.45%로 성장할 것으로 예상됩니다.

반려동물의 수술 건수 증가는 수술 후 통증 관리 약물 수요를 견인하고 있습니다.

반려동물의 의료비 증가와 주인의 우려가 시장 성장을 더욱 촉진하고 있습니다. 미국 반려동물 용품 협회(The American Pet Products Association)의 보고서 2024에 따르면 예측 기간 동안 미국 반려동물 산업의 전반적인 지출이 증가하고 있습니다. 동물 보험의 상당한 증가는 반려동물 주인이 반려동물을 적절하게 돌보는 데 도움이 됩니다. 예를 들어, 2024년 미국에서는 반려동물 관절염과 같은 만성 질환에 대한 반려동물 보험 청구가 최대로 보고되었습니다.

반려동물 수술 후 통증 관리 치료제 시장 : 분석 개요

2024년의 수익 점유율은 개가 46.8%를 차지하고 있습니다. 이것은 개에게 수행되는 수술, 특히 정형외과 및 치과 수술 수가 많기 때문입니다.
비스테로이드성 항염증제(NSAID)는 2024년에 42.4%의 최대 점유율을 차지했습니다. 이 장점은 특히 수술 후 반려동물의 통증과 염증 관리에 NSAID가 널리 사용되기 때문입니다. NSAID는 통증, 붓기 및 발열을 억제하는 효과가 있기 때문에 수의사가 자주 사용하는 약물로 지원됩니다.
경구 약물 부문은 2024년 시장 점유율의 86.6%를 차지했는데, 이는 투여가 쉽고 반려동물 주인이 경구 약물을 선호하기 때문입니다. NSAID와 오피오이드와 같은 경구 통증 관리 약물은 반려동물의 수술 후 관리에 잘 처방됩니다.
동물 병원 및 클리닉 부문은 2024년에 시장을 석권했는데, 이는 이러한 환경에서 수행되는 수술 절차의 양이 많아 효과적인 통증 관리 솔루션이 필요하기 때문입니다.

시장 점유율 : 지역별(2024년·2030년)
시장 대시보드:지역별
시장 규모 예측과 동향 분석 : 지역별(2018-2030년)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 덴마크
- 스웨덴
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

시장 진출기업의 개요
기업의 시장 포지셔닝 분석
기업 분류
전략 매핑
기업 프로파일/상장 기업
- Zoetis
- Merck Animal Health
- Elanco
- Norbrook
- Ceva Sante Animale
- Dechra Pharmaceuticals Plc(EQT)
- Boehringer Ingelheim International GmbH
- Chanelle Pharma(Exponent)
- Bimeda Corporate
- Vetoquinol
기타 주요 기업 목록

제10장 중요한 포인트

JHS 25.03.04

Companion Animal Postoperative Pain Management Therapeutics Market Growth & Trends:

The global companion animal postoperative pain management therapeutics market size is expected to reach USD 329.47 million by 2030, registering to grow at a CAGR of 9.45% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing number of surgeries in companion animals is driving the demand for postoperative pain management drugs.

Increasing companion healthcare expenditure and concerns among pet owners is further propelling the market growth. According to The American Pet Products Association report 2024, the overall spending in U.S. pet industry has increased during forecast period. Significant rise in animal insurance policies helps pet owners take proper care of their pets. For instance, in 2024, maximum pet insurance claims were reported for chronic diseases such as arthritis in pets in U.S. According to a report by the Department of Clinical Veterinary Science and the Pet Food Institute.

Companion Animal Postoperative Pain Management Therapeutics Market Report Highlights:

Dogs accounted for 46.8% of revenue share in 2024. This can be attributed to the high number of surgical procedures performed on dogs, particularly orthopedic surgeries and dental procedures.
NSAIDs held the largest market share of 42.4% in 2024. This dominance is due to the widespread use of NSAIDs in managing pain and inflammation in pets, particularly after surgeries. NSAIDs are favored for their effectiveness in reducing pain, swelling, and fever, making them a go-to choice for veterinarians.
The oral segment held 86.6% of the market share in 2024 attributed to the ease of administration and the preference for oral medications among pet owners. Oral pain management drugs, such as NSAIDs and opioids, are commonly prescribed for postoperative care in companion animals.
The veterinary hospitals and clinics segment dominated the market in 2024 due to the high volume of surgical procedures performed in these settings, which necessitates effective pain management solutions.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Animal
- 1.2.2. Product
- 1.2.3. Route of Administration
- 1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Companion Animal Postoperative Pain Management Therapeutics Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Companion Animal Postoperative Pain Management Therapeutics Market: Animal Business Analysis

4.1. Animal Market Share, 2024 & 2030
4.2. Animal Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.4. Dogs
- 4.4.1. Dogs postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.5. Cats
- 4.5.1. Cats postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.6. Horses
- 4.6.1. Horses postoperative pain management therapeutics market, 2018 - 2030 (USD Million)
4.7. Other companions
- 4.7.1. Other companions postoperative pain management therapeutics market, 2018 - 2030 (USD Million)

Chapter 5. Companion Animal Postoperative Pain Management Therapeutics Market: Product Business Analysis

5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. NSAIDs
- 5.4.1. NSAIDs market, 2018 - 2030 (USD Million)
5.5. Anesthetics
- 5.5.1. Anesthetics market, 2018 - 2030 (USD Million)
5.6. Opioids
- 5.6.1. Opioids market, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Other market, 2018 - 2030 (USD Million)

Chapter 6. Companion Animal Postoperative Pain Management Therapeutics Market: Route of Administration Business Analysis

6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Oral
- 6.4.1. Oral market, 2018 - 2030 (USD Million)
6.5. Injectable
- 6.5.1. Injectable market, 2018 - 2030 (USD Million)

Chapter 7. Companion Animal Postoperative Pain Management Therapeutics Market: End Use Business Analysis

7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Retail
- 7.4.1. Retail market, 2018 - 2030 (USD Million)
7.5. E-commerce
- 7.5.1. E-commerce market, 2018 - 2030 (USD Million)
7.6. Veterinary hospitals & clinics
- 7.6.1. Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)

Chapter 8. Companion Animal Postoperative Pain Management Therapeutics Market: Regional Estimates & Trend Analysis by Animal, Product, Route of Administration, and End Use

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. U.S. companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Canada companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Mexico companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. UK companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Germany companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. France companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Italy companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Spain companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Norway companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Denmark companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Sweden
  - 8.5.9.1. Key country dynamics
  - 8.5.9.2. Sweden companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Japan companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. China companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. India companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. South Korea companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Australia companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Thailand companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Brazil companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Argentina companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. South Africa companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Saudi Arabia companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. UAE companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key country dynamics
  - 8.8.5.2. Kuwait companion animal postoperative pain management therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1. Zoetis
  - 9.5.1.1. Overview
  - 9.5.1.2. Financial performance
  - 9.5.1.3. Product benchmarking
  - 9.5.1.4. Strategic initiatives
- 9.5.2. Merck Animal Health
  - 9.5.2.1. Overview
  - 9.5.2.2. Financial performance
  - 9.5.2.3. Product benchmarking
  - 9.5.2.4. Strategic initiatives
- 9.5.3. Elanco
  - 9.5.3.1. Overview
  - 9.5.3.2. Financial performance
  - 9.5.3.3. Product benchmarking
  - 9.5.3.4. Strategic initiatives
- 9.5.4. Norbrook
  - 9.5.4.1. Overview
  - 9.5.4.2. Financial performance
  - 9.5.4.3. Product benchmarking
  - 9.5.4.4. Strategic initiatives
- 9.5.5. Ceva Sante Animale
  - 9.5.5.1. Overview
  - 9.5.5.2. Financial performance
  - 9.5.5.3. Product benchmarking
  - 9.5.5.4. Strategic initiatives
- 9.5.6. Dechra Pharmaceuticals Plc (EQT)
  - 9.5.6.1. Overview
  - 9.5.6.2. Financial performance
  - 9.5.6.3. Product benchmarking
  - 9.5.6.4. Strategic initiatives
- 9.5.7. Boehringer Ingelheim International GmbH
  - 9.5.7.1. Overview
  - 9.5.7.2. Financial performance
  - 9.5.7.3. Product benchmarking
  - 9.5.7.4. Strategic initiatives
- 9.5.8. Chanelle Pharma (Exponent)
  - 9.5.8.1. Overview
  - 9.5.8.2. Financial performance
  - 9.5.8.3. Product benchmarking
  - 9.5.8.4. Strategic initiatives
- 9.5.9. Bimeda Corporate
  - 9.5.9.1. Overview
  - 9.5.9.2. Financial performance
  - 9.5.9.3. Product benchmarking
  - 9.5.9.4. Strategic initiatives
- 9.5.10. Vetoquinol
  - 9.5.10.1. Overview
  - 9.5.10.2. Financial performance
  - 9.5.10.3. Product benchmarking
  - 9.5.10.4. Strategic initiatives
9.6. List of Other Key Players

반려동물 수술 후 통증 관리 치료제 시장 : 시장 규모, 점유율, 동향 분석(동물별, 제품별, 투여 경로별, 최종 용도별), 부문별 예측(2025-2030년)

Companion Animal Postoperative Pain Management Therapeutics Market Size, Share & Trends Analysis Report By Animal, By Product (NSAIDs, Anesthetics), By Route of Administration, By End-use, And Segment Forecasts, 2025 - 2030

반려동물 수술 후 통증 관리 치료제 시장의 성장과 동향 :

반려동물 수술 후 통증 관리 치료제 시장 : 분석 개요

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 반려동물 수술 후 통증 관리 치료제 시장 : 변동 요인·경향·범위

제4장 동반 동물용 수술 후 통증 관리 치료제 시장 : 동물별 비즈니스 분석

제5장 반려동물 수술 후 통증 관리 치료제 시장 : 제품별 비즈니스 분석

제6장 반려동물 수술 후 통증 관리 치료제 시장 : 투여 경로별 비즈니스 분석

제7장 반려동물 수술 후 통증 관리 치료제 시장 : 최종 용도별 비즈니스 분석

제8장 반려동물 수술 후 통증 관리 치료제 시장 : 지역별 추정과 동향 분석(동물별, 제품별, 투여 경로별, 최종 용도별)